Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Shiff

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
United European Gastroenterology Journal|February 6, 2015
Comparison of adequate relief with symptom, global, and responder endpoints in linaclotide phase 3 trials in IBS-CMichael Camilleri, Anthony J Lembo, Bernard J Lavins, et al.
Plos One|July 30, 2015
Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled TrialBrian E Lacy, Ron Schey, Steven J Shiff, et al.
The American Journal of Gastroenterology|September 19, 2012
Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safetyWilliam D Chey, Anthony J Lembo, Bernard J Lavins, et al.
The American Journal of Gastroenterology|September 19, 2012
A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipationSatish Rao, Anthony J Lembo, Steven J Shiff, et al.
The New England Journal of Medicine|August 12, 2011
Two randomized trials of linaclotide for chronic constipationAnthony J Lembo, Harvey A Schneier, Steven J Shiff, et al.
Journal of Hepatology|July 30, 2023
Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitisArun J Sanyal, Vlad Ratziu, Rohit Loomba, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
United European Gastroenterology Journal|February 6, 2015
Comparison of adequate relief with symptom, global, and responder endpoints in linaclotide phase 3 trials in IBS-CMichael Camilleri, Anthony J Lembo, Bernard J Lavins, et al.
Plos One|July 30, 2015
Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled TrialBrian E Lacy, Ron Schey, Steven J Shiff, et al.
The American Journal of Gastroenterology|September 19, 2012
Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safetyWilliam D Chey, Anthony J Lembo, Bernard J Lavins, et al.
The American Journal of Gastroenterology|September 19, 2012
A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipationSatish Rao, Anthony J Lembo, Steven J Shiff, et al.
The New England Journal of Medicine|August 12, 2011
Two randomized trials of linaclotide for chronic constipationAnthony J Lembo, Harvey A Schneier, Steven J Shiff, et al.
Journal of Hepatology|July 30, 2023
Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitisArun J Sanyal, Vlad Ratziu, Rohit Loomba, et al.
Pageof 2